Arctic Bioscience Share Price

Equities

ABS

NO0010859580

Pharmaceuticals

Market Closed - Oslo Bors 08:15:00 26/04/2024 pm IST 5-day change 1st Jan Change
9.85 NOK 0.00% Intraday chart for Arctic Bioscience -3.43% -6.19%

Financials

Sales 2024 * 57M 5.17M 431M Sales 2025 * 79M 7.17M 597M Capitalization 250M 22.67M 1.89B
Net income 2024 * -30M -2.72M -227M Net income 2025 * -50M -4.54M -378M EV / Sales 2024 * 1.63 x
Net cash position 2024 * 157M 14.24M 1.19B Net cash position 2025 * 106M 9.61M 802M EV / Sales 2025 * 1.82 x
P/E ratio 2024 *
-8.19 x
P/E ratio 2025 *
-4.94 x
Employees 17
Yield 2024 *
-
Yield 2025 *
-
Free-Float 38.42%
More Fundamentals * Assessed data
Dynamic Chart
1 week-3.43%
Current month-1.30%
1 month+3.68%
3 months-6.19%
6 months+25.96%
Current year-6.19%
More quotes
1 week
9.85
Extreme 9.85
10.40
1 month
9.40
Extreme 9.4
10.50
Current year
8.80
Extreme 8.8
12.00
1 year
7.54
Extreme 7.54
12.00
3 years
7.54
Extreme 7.54
25.00
5 years
7.54
Extreme 7.54
32.00
10 years
7.54
Extreme 7.54
32.00
More quotes
Managers TitleAgeSince
Founder 58 01/11/01
Chief Executive Officer 52 01/22/01
Director of Finance/CFO 45 01/22/01
Members of the board TitleAgeSince
Director/Board Member 44 01/21/01
Director/Board Member 55 01/20/01
Founder 66 01/11/01
More insiders
Date Price Change Volume
26/24/26 9.85 0.00% 0
25/24/25 9.85 0.00% 0
24/24/24 9.85 0.00% 0
23/24/23 9.85 -5.29% 900
22/24/22 10.4 +1.96% 4,265

Real-time Oslo Bors, April 26, 2024 at 08:15 pm IST

More quotes
Arctic Bioscience AS is a Norway-based biotech company developing and commercializing both pharmaceutical and nutraceutical products based on the properties of herring roe oil. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The Company is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The Company's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.85 NOK
Average target price
10 NOK
Spread / Average Target
+1.52%
Consensus

Annual profits - Rate of surprise